Nuvalent
Initial Transaction Details
Transaction Date
February 2017
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Debt and Equity
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, Nuvalent develops innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses.
Website